Fmr LLC Nurix Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 75,646 shares of NRIX stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,646

Previous 71,362 6.0%

Holding current value

$1.9 Million

Previous $1.05 Million 50.43%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.02 - $21.3 $51,493 - $91,249	4,284 Added 6.0%	75,646 $1.58 Million
Q1 2024 May 13, 2024	SELL	$7.77 - $15.66 $1.96 Million - $3.95 Million	-252,367 Reduced 77.96%	71,362 $1.05 Million
Q4 2023 Feb 13, 2024	BUY	$4.25 - $10.71 $11,993 - $30,223	2,822 Added 0.88%	323,729 $3.34 Million
Q3 2023 Nov 13, 2023	SELL	$7.86 - $10.08 $752,249 - $964,716	-95,706 Reduced 22.97%	320,907 $2.52 Million
Q2 2023 Aug 11, 2023	SELL	$8.7 - $13.28 $292,589 - $446,619	-33,631 Reduced 7.47%	416,613 $4.16 Million
Q1 2023 May 11, 2023	SELL	$8.56 - $13.26 $4.74 Million - $7.34 Million	-553,399 Reduced 55.14%	450,244 $4 Million
Q4 2022 Feb 13, 2023	SELL	$9.86 - $14.59 $6.72 Million - $9.95 Million	-682,008 Reduced 40.46%	1,003,643 $11 Million
Q3 2022 Nov 10, 2022	SELL	$12.33 - $19.81 $1.29 Million - $2.08 Million	-105,004 Reduced 5.86%	1,685,651 $22 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $5.27 Million - $9.91 Million	668,632 Added 59.59%	1,790,655 $22.7 Million
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $180,124 - $412,728	13,920 Added 1.26%	1,122,023 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$26.43 - $34.5 $11.9 Million - $15.5 Million	449,486 Added 68.25%	1,108,103 $32.1 Million
Q2 2021 Aug 13, 2021	BUY	$24.21 - $35.89 $15.9 Million - $23.6 Million	658,617 New	658,617 $17.5 Million

Others Institutions Holding NRIX

# of Institutions

183

Shares Held

66.4M

Call Options Held

40.9K

Put Options Held

106K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.18B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account